35058089|t|Etanercept Reduces Neuron Injury and Neuroinflammation via Inactivating c-Jun N-terminal Kinase and Nuclear Factor-kappaB Pathways in Alzheimer's Disease: An In Vitro and In Vivo Investigation.
35058089|a|Inflammation contributes to amyloid beta (Abeta) aggregation and neuron loss in Alzheimer's disease (AD). Meanwhile, tumor necrosis factor-alpha (TNF-alpha) inhibitors present strong effect on suppressing inflammation. Thus, this study aimed to investigated the effect and molecular mechanism of etanercept (ETN) (a commonly used TNF-alpha inhibitor) on neuron injury and neuroinflammation in AD. AD cellular model was constructed by co-culture of primary embryonic neuron cells and microglial cells, followed by Abeta treatment. Subsequently, ETN was used to treat AD cellular model. Besides, APPswe/PS1M146V/tauP301L transgenic (AD) mice were respectively treated with saline or ETN by intravenous injection once per 3 days for 10 times. In vitro data revealed that cell viability and neurite outgrowth were increased, but apoptosis and levels of pro-inflammatory cytokines (including TNF-alpha, interleukin-1beta, Interleukin-6 and C-C motif chemokine ligand 2 (CCL2)) were decreased by ETN treatment in AD cellular model. In vivo experiments found that ETN treatment improved spatial, long-term memory (reflected by Morrison water maze) and working memory (reflected by Y maze) in AD mice. Besides, ETN treatment reduced neuron injury (reflected by Hematoxylin-Eosin (HE) and terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) assays) and levels of pro-inflammatory cytokines (including TNF-alpha, interleukin-1beta, Interleukin-6 and CCL2) in AD mice. Moreover, ETN repressed the activation of c-Jun N-terminal kinase (JNK) and nuclear factor-kappaB (NF-kappaB) pathways in AD both in vitro and in vivo. In conclusion, ETN exerts neuroprotective function via inactivating JNK and NF-kappaB pathways in AD, indicating the potential of ETN for improving AD management.
35058089	19	32	Neuron Injury	Disease	MESH:D009410
35058089	37	54	Neuroinflammation	Disease	MESH:D000090862
35058089	72	95	c-Jun N-terminal Kinase	Gene	26419
35058089	100	121	Nuclear Factor-kappaB	Gene	18033
35058089	134	153	Alzheimer's Disease	Disease	MESH:D000544
35058089	194	206	Inflammation	Disease	MESH:D007249
35058089	236	241	Abeta	Gene	11820
35058089	259	270	neuron loss	Disease	MESH:D009410
35058089	274	293	Alzheimer's disease	Disease	MESH:D000544
35058089	295	297	AD	Disease	MESH:D000544
35058089	311	338	tumor necrosis factor-alpha	Gene	21926
35058089	340	349	TNF-alpha	Gene	21926
35058089	399	411	inflammation	Disease	MESH:D007249
35058089	524	533	TNF-alpha	Gene	21926
35058089	548	561	neuron injury	Disease	MESH:D009410
35058089	566	583	neuroinflammation	Disease	MESH:D000090862
35058089	587	589	AD	Disease	MESH:D000544
35058089	591	593	AD	Disease	MESH:D000544
35058089	707	712	Abeta	Gene	11820
35058089	760	762	AD	Disease	MESH:D000544
35058089	798	803	M146V	ProteinMutation	tmVar:p|SUB|M|146|V;HGVS:p.M146V;VariantGroup:1;OriginalGene:21926;CorrespondingGene:7124;CorrespondingSpecies:10090
35058089	807	812	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;OriginalGene:21926;CorrespondingGene:7124;CorrespondingSpecies:10090
35058089	825	827	AD	Disease	MESH:D000544
35058089	829	833	mice	Species	10090
35058089	1047	1059	inflammatory	Disease	MESH:D007249
35058089	1081	1090	TNF-alpha	Gene	21926
35058089	1092	1109	interleukin-1beta	Gene	16176
35058089	1111	1124	Interleukin-6	Gene	16193
35058089	1129	1157	C-C motif chemokine ligand 2	Gene	20296
35058089	1159	1163	CCL2	Gene	20296
35058089	1201	1203	AD	Disease	MESH:D000544
35058089	1379	1381	AD	Disease	MESH:D000544
35058089	1382	1386	mice	Species	10090
35058089	1419	1432	neuron injury	Disease	MESH:D009410
35058089	1447	1458	Hematoxylin	Chemical	MESH:D006416
35058089	1466	1468	HE	Chemical	-
35058089	1574	1586	inflammatory	Disease	MESH:D007249
35058089	1608	1617	TNF-alpha	Gene	21926
35058089	1619	1636	interleukin-1beta	Gene	16176
35058089	1638	1651	Interleukin-6	Gene	16193
35058089	1656	1660	CCL2	Gene	20296
35058089	1665	1667	AD	Disease	MESH:D000544
35058089	1668	1672	mice	Species	10090
35058089	1716	1739	c-Jun N-terminal kinase	Gene	26419
35058089	1741	1744	JNK	Gene	26419
35058089	1750	1771	nuclear factor-kappaB	Gene	18033
35058089	1773	1782	NF-kappaB	Gene	18033
35058089	1796	1798	AD	Disease	MESH:D000544
35058089	1894	1897	JNK	Gene	26419
35058089	1902	1911	NF-kappaB	Gene	18033
35058089	1924	1926	AD	Disease	MESH:D000544
35058089	1974	1976	AD	Disease	MESH:D000544
35058089	Association	MESH:D000544	20296
35058089	Association	MESH:D000544	21926
35058089	Association	MESH:D007249	20296
35058089	Association	MESH:D000544	26419
35058089	Association	MESH:D000090862	18033
35058089	Association	MESH:D000544	HGVS:p.M146V;CorrespondingGene:7124
35058089	Association	MESH:D007249	16176
35058089	Association	MESH:D000544	16193
35058089	Association	MESH:D000544	18033
35058089	Association	MESH:D000544	16176
35058089	Association	MESH:D009410	18033
35058089	Association	MESH:D007249	11820
35058089	Association	MESH:D007249	21926
35058089	Association	MESH:D007249	16193
35058089	Association	MESH:D000544	7124

